{"id":"W2590468594","doi":"10.1182/blood.v108.11.574.574","title":"A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Apixaban; Warfarin; Surgery; Deep vein; Pulmonary embolism; Thrombosis; Venography; Anesthesia; Rivaroxaban; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003401405,0.002895317,0.004571173,0.0007276144,0.0007575622,0.00161496,0.001594134,0.00264714,0.008329399],"category_scores_gemma":[0.003636935,0.001378583,0.001655303,0.0006502346,0.001814347,0.001582881,0.000521188,0.005021422,0.002055323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008006468,"about_ca_system_score_gemma":0.001983302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005344116,"about_ca_topic_score_gemma":0.001068572,"domain_scores_codex":[0.998745,0.0006564952,0.00007626063,0.0002524087,0.0001105187,0.0001592736],"domain_scores_gemma":[0.9981518,0.0005028189,0.0003598031,0.0002118656,0.0001935143,0.0005801286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9688339,0.01912212,0.0002721277,0.000436357,0.0004696554,0.00002396532,0.0000527988,0.0002594868,0.002896703,0.0001055378,0.0008906918,0.006636707],"study_design_scores_gemma":[0.9777678,0.02119464,0.0003030038,0.000008059762,0.00007442124,0.00000954904,0.000005873911,0.0001967471,0.0001485302,0.00006044406,0.000225046,0.000005946184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9523639,0.003892305,0.003705106,0.001481007,0.002150203,0.02869688,0.002987703,0.0005287401,0.004194135],"genre_scores_gemma":[0.9329036,0.003729886,0.007088832,0.003478223,0.001442433,0.04065112,0.003189708,0.0001503011,0.00736577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008329399,"threshold_uncertainty_score":0.02786458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05075478254133818,"score_gpt":0.3166640178408113,"score_spread":0.2659092352994731,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}